Maryaline Catillon

Manager
Maryaline Catillon

Education

Ph.D., health policy, Harvard University; M.P.H., Pasteur Institute-CNAM School of Public Health; LL.M. and LL.B., Toulouse University; M.A., contemporary history and political science, Paris University; B.S., mathematics and physics, Paris University

Summary of Experience

Dr. Catillon specializes in health economics and outcomes research (HEOR) and epidemiology. Her areas of expertise include the design of real-world studies, chart reviews, surveys, discrete choice experiments; retrospective database analyses using medical claims, electronic health records, and clinical trial data; indirect treatment comparisons such as matching-adjusted indirect comparisons and network meta-analyses; and machine learning applications. Her work encompasses therapeutic fields such as oncology, infectious diseases, ophthalmology, and psychiatry. Dr. Catillon’s research has been presented at international conferences and published in peer-reviewed journals such as Health Economics, Leukemia & Lymphoma, and The Journal of Clinical Psychiatry. She has served as a peer reviewer for journals such as The BMJ, Health Services Research, and Management Science. She has taught at Harvard University and the NYU Grossman School of Medicine, and is affiliated with the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). Dr. Catillon serves as an expert on the scientific advisory board of projects funded by Horizon Europe, the EU’s research and innovation program (REMEDIA). She is vice president of the Sergei S. Zlinkoff Fund for Medical Research and Education. Prior to joining Analysis Group, Dr. Catillon was the CFO of a hospital in France.